Media Release

All Categories

28 October 2019

Immunology Company Kira Biotech launches with $20M Series A Funding

21 August 2019

Blade Therapeutics announces publication of preclinical data supporting Calpain 9 as a promising therapeutic target for fibriotic disease

17 June 2019

Leading Airbnb Property Management Company, Hometime, announces $6M funding round with OneVentures, in inaugural venture debt deal

04 May 2019

US biotech heavyweights join OneVentures

07 April 2019

OneVentures reaches first close of Australia’s first venture credit fund

16 September 2018

VC-backed women’s health company Madorra to begin clinical trials in Australia

13 August 2018

OneVentures invests in regional Queensland company developing treatments for autoimmune diseases

05 August 2018

Australian First:-Israeli venture partnership launches new Venture Credit Fund to invest in high-growth technology companies

23 May 2018

Prota/MCRI completes enrolment of Phase 2b multicentre clinical trial of probiotic oral immunotherapy for the treatment of peanut allergy (PPOIT-003)

16 May 2018

Biomedical Translation Fund invests in further development of total artificial heart device

18 April 2018

Prota Therapeutics partners with world leading bioscience company, Chr. Hansen

05 February 2018

OneVentures’ Investee Smart Sparrow Secures Strategic Investment from Global Education Leader

04 February 2018

Find-me appoints Rachel Boden as new CEO

04 September 2017

Citadel Group aquires OneVentures portfolio company Charm Health

29 May 2017

OneVentures Boosts Healthcare Team

27 May 2017

OneVentures makes first investment for the Biomedical Translation Fund

07 April 2017

Australia’s ProTA accelerates the development of immunotherapy to treat peanut allergy

19 February 2017

Find-Me Technologies Strengthens the Board in Readiness for Rapid Growth

Announcement, Media Release

13 December 2016

OneVentures awarded Biomedical Translation $170M Funding

Announcement, Media Release

18 October 2016

Clinical Genomics Strenghtens it’s Leadership Team with Multiple Key Appointments

18 October 2016

Data published in Cancer Medicine Demostrate Clinical Genomics’ Blood Test for Colorectal Cancer Recurrence is Two-Fold More Sensitive than CEA Test

31 August 2016

OneVentures appoints Dr Graeme Wald to life sciences investment team

18 July 2016

DoseMe partners with Charm Health to improve management of high risk oncology medicines and deliver “precision medicine” to Australian cancer patients

19 April 2016

Icon Group signs up Charm Health to support cancer care

decor decor decor
decor decor decor decor decor